Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 42% ± 21% | |
lung | 13 studies | 28% ± 12% | |
eye | 9 studies | 36% ± 18% | |
peripheral blood | 5 studies | 24% ± 6% | |
heart | 5 studies | 27% ± 7% | |
intestine | 5 studies | 22% ± 6% | |
adipose | 4 studies | 41% ± 20% | |
kidney | 4 studies | 25% ± 7% | |
liver | 3 studies | 38% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3865.94 | 1445 / 1445 | 100% | 41.86 | 183 / 183 |
lung | 100% | 3792.08 | 578 / 578 | 100% | 30.73 | 1155 / 1155 |
ovary | 100% | 4879.46 | 180 / 180 | 100% | 20.17 | 429 / 430 |
breast | 100% | 4191.13 | 459 / 459 | 99% | 32.44 | 1110 / 1118 |
prostate | 100% | 3287.91 | 245 / 245 | 99% | 25.63 | 497 / 502 |
uterus | 100% | 4299.38 | 170 / 170 | 99% | 32.37 | 454 / 459 |
thymus | 100% | 3935.09 | 653 / 653 | 99% | 26.92 | 598 / 605 |
pancreas | 100% | 2099.02 | 327 / 328 | 99% | 28.31 | 176 / 178 |
bladder | 100% | 3623.33 | 21 / 21 | 98% | 28.77 | 496 / 504 |
kidney | 100% | 2204.64 | 89 / 89 | 98% | 25.11 | 882 / 901 |
brain | 98% | 1713.33 | 2601 / 2642 | 99% | 23.71 | 701 / 705 |
intestine | 100% | 3829.73 | 966 / 966 | 98% | 26.59 | 514 / 527 |
stomach | 100% | 2545.15 | 359 / 359 | 97% | 28.79 | 278 / 286 |
skin | 100% | 4038.02 | 1809 / 1809 | 92% | 24.08 | 434 / 472 |
adrenal gland | 100% | 3798.79 | 258 / 258 | 91% | 12.57 | 209 / 230 |
liver | 100% | 1682.01 | 226 / 226 | 86% | 11.51 | 351 / 406 |
blood vessel | 100% | 3248.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3412.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.97 | 1 / 1 |
adipose | 100% | 4123.33 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1669.27 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1743.78 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 17.04 | 65 / 80 |
peripheral blood | 81% | 1791.67 | 751 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 7.95 | 20 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0043297 | Biological process | apical junction assembly |
GO_0010631 | Biological process | epithelial cell migration |
GO_0007165 | Biological process | signal transduction |
GO_0051301 | Biological process | cell division |
GO_0007155 | Biological process | cell adhesion |
GO_0030030 | Biological process | cell projection organization |
GO_0045070 | Biological process | positive regulation of viral genome replication |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0035556 | Biological process | intracellular signal transduction |
GO_2000145 | Biological process | regulation of cell motility |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0032467 | Biological process | positive regulation of cytokinesis |
GO_0030496 | Cellular component | midbody |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0043296 | Cellular component | apical junction complex |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0032154 | Cellular component | cleavage furrow |
GO_0030027 | Cellular component | lamellipodium |
GO_0005634 | Cellular component | nucleus |
GO_0070063 | Molecular function | RNA polymerase binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0031267 | Molecular function | small GTPase binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0003723 | Molecular function | RNA binding |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | PKN2 |
Protein name | Protein kinase N2 PKN2 protein Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) |
Synonyms | PRK2 PRKCL2 hCG_23733 |
Description | FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis . .; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. . |
Accessions | ENST00000370513.9 [Q16513-3] H0Y5V5 Q8N2Y1 Q16513 ENST00000436111.1 ENST00000370521.8 [Q16513-1] H0Y429 B1AL79 ENST00000449189.1 Q6P5W9 ENST00000316005.11 |